Research progress on accurate treatment of bronchial asthma

Wang Luo,Yujie Qiao,Cuiping Ye,Shaoxi Cai,Hangming Dong
DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2020.05.011
2020-01-01
Abstract:Bronchial asthma (asthma) is a heterogeneous disease characterized by chronic airway inflammation.It is one of the most common chronic diseases in the world which causes huge medical burden.Although the symptoms of most asthma patients can be effectively controlled by inhaled glucocorticoids and bronchodilators,some patients with severe asthma are still unable to achieve ideal control under conventional treatment.Therefore,more and more attention has been paid to targeted drugs at the molecular level.The purpose of this review is to discuss the current research progress in accurate treatment of asthma and to explore the application value of targeted therapy drugs in the treatment of severe asthma.
What problem does this paper attempt to address?